Non-invasive Test to Detect Intra-amniotic Infection in Women With Preterm Labor and Intact Amniotic Membranes

NCT00700219 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2010-07-21

No results posted yet for this study

Summary

The purpose of this study is to collect clinical specimens and corresponding clinical data to develop a non-invasive test for detection of intra-amniotic infection and prediction of preterm birth in women and intact amniotic membranes. The specimens collected will be used to develop a specific biomarker panel and algorithm using immunoassays for optimal detection of intra-amniotic infection in women with preterm labor and intact amniotic membranes.

Conditions

  • Intra-amniotic Infection

Sponsors & Collaborators

  • Obstetrix Medical Group

    collaborator INDUSTRY
  • ProteoGenix, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew Combs, MD, PhD · Obstetrix Medical Group of California

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00700219 on ClinicalTrials.gov